Glycogen Storage Disease Type V

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Glycogen Storage Disease Type V trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (19 shown)

CompletedPhase 2

NCT02919631

Triheptanoin in Mc Ardle

Background: Patients with the sugar metabolism disorder, Glycogen Storage Disease Type V, have insufficient breakdown of sugar stored as, glycogen, within the c…

France12 participantsStarted 2016-11-16

Treatment: Triheptanoin, Placebo oil

Active — Not RecruitingNot Applicable

NCT05943678

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Previous studies have indicated that 13C-MRS in the ultra-high 7T magnetic resonance (MR) field is a potential non-invasive measurement method for assessing cha…

Austria30 participantsStarted 2023-08-15

Treatment: Siemens Magnetom 7T Plus

Glycogen Storage Disease Type V

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (19 shown)

Triheptanoin in Mc Ardle

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (19 shown)

Triheptanoin in Mc Ardle

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases

Glycosade v UCCS in the Dietary Management of Hepatic GSD

Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)

MRI in McArdle Disease (GSDV)

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Modified Ketogenic Diet in Patients With McArdle Disease Part B

Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases

A Study of the Safety of REN001 in Patients With McArdle Disease

McArdle Disease Treatment by Ketogenic Diet

Oral Ketone Body Supplementation in Patients With McArdle Disease

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)

Muscle Relaxation in Myopathies With Positive Muscle Phenomena

Modified Ketogenic Diet in Patients With McArdle Disease Part A

Sodium Valproate for GSDV

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies